Sandra Lechner

2.6k total citations · 2 hit papers
27 papers, 1.8k citations indexed

About

Sandra Lechner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Sandra Lechner has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Oncology. Recurrent topics in Sandra Lechner's work include Neuroscience and Neuropharmacology Research (6 papers), Receptor Mechanisms and Signaling (6 papers) and Ion channel regulation and function (4 papers). Sandra Lechner is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Receptor Mechanisms and Signaling (6 papers) and Ion channel regulation and function (4 papers). Sandra Lechner collaborates with scholars based in United States, Germany and Spain. Sandra Lechner's co-authors include Rita J. Valentino, Andre L. Curtis, Luis A. Pavcovich, Alan C. Foster, Peter Hevezi, Albert Zlotnik, Dorian Willhite, Richard B. Roth, Jerry Lee and Rebecca L. Cole and has published in prestigious journals such as New England Journal of Medicine, The Journal of Comparative Neurology and Gut.

In The Last Decade

Sandra Lechner

27 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective Inhibition of Na _V 1.8 with VX-548 for Acute Pain

2023 110 citations J. W. Jones, Darin Correll et al. New England Journal of Medicine profile →
Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain

2025 44 citations Jeremiah D. Osteen, Tim Indersmitten et al. Pain and Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Lechner United States	20	785	553	280	280	167	27	1.8k
Zbigniew S. Herman Poland	24	648 0.8×	539 1.0×	287 1.0×	289 1.0×	129 0.8×	110	2.1k
Julie A. Ellison United States	18	1.2k 1.6×	658 1.2×	146 0.5×	395 1.4×	86 0.5×	24	2.9k
Paul J. L. M. Strijbos United Kingdom	28	740 0.9×	707 1.3×	224 0.8×	634 2.3×	115 0.7×	37	2.3k
Jari Honkaniemi Finland	32	974 1.2×	1.0k 1.8×	334 1.2×	261 0.9×	211 1.3×	49	2.7k
Junko Imaki Japan	24	846 1.1×	580 1.0×	272 1.0×	243 0.9×	184 1.1×	63	2.1k
Giuliano Neri Italy	28	646 0.8×	676 1.2×	431 1.5×	489 1.7×	133 0.8×	95	2.1k
Leonard P. Miller United States	27	781 1.0×	1.3k 2.3×	111 0.4×	360 1.3×	84 0.5×	54	2.5k
Carole Rovère France	32	816 1.0×	571 1.0×	133 0.5×	425 1.5×	63 0.4×	63	2.8k
Junichi Kitanaka Japan	22	759 1.0×	693 1.3×	75 0.3×	162 0.6×	63 0.4×	85	1.5k
Masayo Fujita Japan	28	1.0k 1.3×	572 1.0×	194 0.7×	571 2.0×	59 0.4×	64	2.7k

Countries citing papers authored by Sandra Lechner

Since Specialization

Citations

This map shows the geographic impact of Sandra Lechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Lechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Lechner more than expected).

Fields of papers citing papers by Sandra Lechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Lechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Lechner. The network helps show where Sandra Lechner may publish in the future.

Co-authorship network of co-authors of Sandra Lechner

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Lechner. A scholar is included among the top collaborators of Sandra Lechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Lechner. Sandra Lechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osteen, Jeremiah D., et al.. (2025). Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain. Pain and Therapy. 14(2). 655–674. 44 indexed citations breakdown →

Jones, J. W., Darin Correll, Sandra Lechner, et al.. (2023). Selective Inhibition of Na _V 1.8 with VX-548 for Acute Pain. New England Journal of Medicine. 389(5). 393–405. 110 indexed citations breakdown →

Lechner, Sandra, Achraf Ammar, Omar Boukhris, et al.. (2022). Monitoring training load in youth soccer players: effects of a six-week preparatory training program and the associations between external and internal loads. Biology of Sport. 40(1). 63–75. 14 indexed citations

Grigoriadis, Dimitri E., Samuel R.J. Hoare, Sandra Lechner, Deborah H. Slee, & John A. Williams. (2008). Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels. Neuropsychopharmacology. 34(1). 106–125. 31 indexed citations

Moorjani, M. N., Xiaohu Zhang, Yongsheng Chen, et al.. (2008). 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A2A antagonists with reduced hERG liability. Bioorganic & Medicinal Chemistry Letters. 18(4). 1269–1273. 5 indexed citations

Moorjani, M. N., Zhiyong Luo, Binh G. Vong, et al.. (2008). 2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A2A antagonists with improved solubility and metabolic stability. Bioorganic & Medicinal Chemistry Letters. 18(20). 5402–5405. 9 indexed citations

Gu, Guibao, Daniel S. Lorrain, Hongbing Wei, et al.. (2008). Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition. Brain Research. 1197. 47–62. 81 indexed citations

Maki, R., Peter Hevezi, Gail Verge, et al.. (2006). Experimental Autoimmune Encephalomyelitis Develops in CC Chemokine Receptor 7‐deficient Mice with Altered T‐cell Responses. Scandinavian Journal of Immunology. 64(4). 361–369. 22 indexed citations

Selkirk, Julie V., et al.. (2006). Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology. 52(2). 459–466. 28 indexed citations

10.

Selkirk, Julie V., Lisa Nottebaum, Mark Santos, et al.. (2006). A Novel Cell-Based Assay for G-Protein-Coupled Receptor–Mediated Cyclic Adenosine Monophosphate Response Element Binding Protein Phosphorylation. SLAS DISCOVERY. 11(4). 351–358. 18 indexed citations

11.

Cole, Rebecca L., Sandra Lechner, Mark E. Williams, et al.. (2005). Differential distribution of voltage‐gated calcium channel alpha‐2 delta (α₂δ) subunit mRNA‐containing cells in the rat central nervous system and the dorsal root ganglia. The Journal of Comparative Neurology. 491(3). 246–269. 176 indexed citations

12.

Lechner, Sandra, Ulf Müller‐Ladner, Elena Neumann, et al.. (2003). Thioredoxin Reductase 1 Expression in Colon Cancer: Discrepancy between In Vitro and In Vivo Findings. Laboratory Investigation. 83(9). 1321–1331. 18 indexed citations

13.

Neumann, Elena, Sandra Lechner, Ingo H. Tarner, et al.. (2003). Evaluation of differentially expressed genes by a combination of cDNA array and RAP–PCR using the AtlasImage™ 2.0 software. Journal of Autoimmunity. 21(2). 161–166. 3 indexed citations

14.

Judex, Martin, Elena Neumann, Sandra Lechner, et al.. (2003). Laser‐mediated microdissection facilitates analysis of area‐specific gene expression in rheumatoid synovium. Arthritis & Rheumatism. 48(1). 97–102. 26 indexed citations

15.

Lechner, Sandra, Ulf Müller‐Ladner, Klaus Schlottmann, et al.. (2002). Bile acids mimic oxidative stress induced upregulation of thioredoxin reductase in colon cancer cell lines. Carcinogenesis. 23(8). 1281–1288. 72 indexed citations

16.

Bell, Stanley C., Michael De Vivo, Sandra Lechner, et al.. (2001). ALX 5407: A Potent, Selective Inhibitor of the hGlyT1 Glycine Transporter. Molecular Pharmacology. 60(6). 1414–1420. 140 indexed citations

17.

Maurice, Madelon M., Hajime Nakamura, Sonja I. Gringhuis, et al.. (1999). Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis & Rheumatism. 42(11). 2430–2439. 95 indexed citations

18.

Lechner, Sandra & Rita J. Valentino. (1999). Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus. Brain Research. 816(1). 17–28. 45 indexed citations

19.

Lechner, Sandra, et al.. (1997). Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Research. 756(1-2). 114–124. 115 indexed citations

20.

Curtis, Andre L., Sandra Lechner, Luis A. Pavcovich, & Rita J. Valentino. (1997). Activation of the Locus Coeruleus Noradrenergic System by Intracoerulear Microinfusion of Corticotropin-Releasing Factor: Effects on Discharge Rate, Cortical Norepinephrine Levels and Cortical Electroencephalographic Activity. Journal of Pharmacology and Experimental Therapeutics. 281(1). 163–172. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact